Drug intelligence / Profile preview

Vitalose

Development stage: Preclinical
Lead developer: Beneo
Administration: Oral

Overview

Vitalose is a dietary supplement developed by Beneo-Institute, currently under investigation for its impact on postprandial glucose and insulin responses. Beneo-Institute specializes in the development of functional ingredients, such as specific carbohydrates, that aim to modulate metabolic reactions to food intake. The clinical trial involving Vitalose seeks to assess how it affects blood glucose and insulin levels after consumption, suggesting its potential role in nutritional management related to carbohydrate metabolism.

Beyond the preview

Go deeper on Vitalose.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitalose.

Explore the full profile